New Drugs FDA Approves Label Extension for Evrysdi for Infants with Spinal Muscular Atrophy Under 2 Months Old 3 years ago
Pharma Industry News Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy 3 years ago
Pharma Industry News Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities 3 years ago
Pharma Industry News Leipzig/Halle Airport region in Germany joins forces to attract investors 3 years ago
Healthcare News How Does The COVID-19 Prevention Drug Evusheld Work And Who Should Receive It? 3 years ago
Pharma Industry News NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer 3 years ago
Pharma Industry News Novartis’ Kymriah receives FDA approval to treat follicular lymphoma 3 years ago